Nostrum Laboratories, Inc. has recalled type 2 diabetes drug Metformin as N-Nitrosodimethylamine or NDMA, a probable human carcinogen, exceeds acceptable daily intake or ADI limit established by the U.S. Food and Drug Administration. The recall involves 2 lots each of Metformin HCl Extended Release tablets USP 750 mg and 500 mg to the consumer level.
from RTT - Biotech https://ift.tt/2I15D0Q
via IFTTT
No comments:
Post a Comment